+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Bioprinting: Technologies and Global Markets

  • PDF Icon

    Report

  • 105 Pages
  • January 2023
  • Region: Global
  • BCC Research
  • ID: 5715388

This report incorporates an in-depth analysis of the bioprinting market, including market estimations and trends through 2020. Major players, competitive intelligence, innovative technologies, market dynamics, and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The patent analysis focuses on technological trends in recent years in regions such as the U.S., Europe, and Japan. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for bioprinting technologies.

The scope of the report extends to only those bioprinting technologies that generate the most global revenue. Surgical device or guides and ceramics or metal devices used in 3D bioprinting overlap with other products that are already covered under the technology segments, so these have been excluded.

This report segments the global market by these geographic regions: North America, Europe, Asia-Pacific, and the Rest of the World region. For market estimates, data is provided for 2020, as the base year 2021 and forecast through year-end 2027.

Report Includes

  • 26 data tables and 35 additional tables
  • An up-to-date review and analysis of the global markets for bioprinting technologies and applications within the industry
  • Analyses of the global market trends, with market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of market opportunities for this innovation-driven market, and the major regions and countries involved in market developments
  • Estimation of the actual market size and revenue forecast for global bioprinting market in USD millions, and corresponding market share analysis by type of technology, application, end-user, and region
  • Technology assessment of the key drivers, restraints and opportunities that will shape the market for bioprinting over the forecast period (2022 to 2027)
  • Analysis of the markets for the main bioprinting end-use applications, including research, drug discovery and development, cosmetics, and clinical
  • Discussion of the industry value chain analysis providing a systematic study of key intermediaries involved, with emphasis on technologies, applications, and end users of bioprinting
  • Updated information on recent industry acquisitions, partnerships, agreements, collaborations, and other strategic alliances in the global bioprinting market
  • Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
  • Profile descriptions of the market leading participants, including 3D Bio Corp., Advanced Solutions Inc., Cellink, Organovo, and Stratasys Ltd.
Frequently Asked Questions about the Global Bioprinting Market

What is the estimated value of the Global Bioprinting Market?

The Global Bioprinting Market was estimated to be valued at $2.4 Billion in 2022.

What is the growth rate of the Global Bioprinting Market?

The growth rate of the Global Bioprinting Market is 16.2%, with an estimated value of $5 Billion by 2027.

What is the forecasted size of the Global Bioprinting Market?

The Global Bioprinting Market is estimated to be worth $5 Billion by 2027.

Who are the key companies in the Global Bioprinting Market?

Key companies in the Global Bioprinting Market include 3D Bio Corp., 3D Bioprinting Solutions, 3D Systems Inc., Advanced Solutions Inc., Aspect Biosystems Ltd., Cellink, Collplant Biotechnologies Ltd., Cyfuse Biomedical and Precise Bio.

Table of Contents

Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing this Study
1.3 What's New in this Report?
1.4 Scope of Report
1.5 Information Sources
1.6 Methodology
1.7 Geographic Breakdown
1.8 Analyst's Credentials
1.9 Custom Research
1.10 Related Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market Overview
3.1 Bioprinting Product Life Cycle
3.2 Bioprinting Industry
3.3 Bioprinting Instrument Technologies
3.3.1 Software
3.3.2 Organ-On-Chip
3.4 Organs and Organoids
3.4.1 Organoids
3.4.2 Organs
3.5 Technological Challenges in Printing Organs
3.6 Bioprinting Applications
3.7 Innovations in Medical/Healthcare Products
3.7.1 Diagnosing Diseases
3.7.2 Monitoring Patients
3.7.3 Personalized Medicine
3.8 Current Trends
3.8.1 Enhanced Cybersecurity
3.8.2 Internet of Medical Things (Iomt)
3.8.3 Medical Robots
3.8.4 3D Printed Objects
3.8.5 Device Connectivity
3.9 Regulations and Legislation
3.9.1 Europe
3.9.2 U.S.
3.9.3 Japan

Chapter 4 Market Dynamics
4.1 Market Dynamics
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Strategies
4.1.5 Trends

Chapter 5 Impact of the Covid-19 Pandemic
5.1 Impact of Covid-19 on the Market for Bioprinting
5.1.1 Personal Protective Equipment (Ppe)
5.1.2 Face Masks
5.1.3 Face Shields
5.1.4 3D Printing in Healthcare

Chapter 6 Global Market for Bioprinting Technologies
6.1 Overview
6.2 Droplet Disposition
6.2.1 Market Outlook
6.3 Photopolymerization
6.3.1 Market Outlook

Chapter 7 Global Market for Bioprinting End Uses
7.1 Overview
7.2 Drug Discovery and Development
7.2.1 Market Outlook
7.3 Research
7.4 Cosmetics
7.5 Other End Uses

Chapter 8 Global Market for Bioprinting Technologies by Region
8.1 Overview
8.2 North America
8.2.1 Market Outlook
8.3 Europe
8.3.1 Market Outlook
8.4 Asia-Pacific
8.4.1 Market Outlook
8.5 Rest of the World
8.5.1 Market Outlook

Chapter 9 Competitive Landscape

Chapter 10 Company Profiles

  • 3D Bio Corp.
  • 3D Bioprinting Solutions
  • 3D Systems Inc.
  • Advanced Solutions Inc.
  • Aspect Biosystems Ltd.
  • Cellink
  • Cyfuse Biomedical
  • Collplant Biotechnologies Ltd.
  • Organovo Holding Inc.
  • Precise Bio
  • Stratasys Ltd.
  • Other Companies

List of Tables
Summary Table: Global Market for Bioprinting Technologies, by Type, Through 2027
Table 1: Life Cycle of Bioprinting Products
Table 2: Characteristics of Bioprinting Industry Segments
Table 3: Comparison of Bioprinting with 3D Printing
Table 4: Bioprinting Instrument Technologies
Table 5: Public Policy Issues Related to Bioprinted Organs
Table 6: Bioprinting of Organs: Technological Challenges
Table 7: Bioprinting Applications
Table 8: Class I and II Exempt Devices
Table 9: Applications of Bioprinting in Cancer Tissue Engineering
Table 10: 3D Bioprinting Technologies in Development for COVID-19 Vaccines and Therapeutics
Table 11: Global Market for Bioprinting Technologies, by Type, Through 2027
Table 12: Global Market for Bioprinting Technologies, by Type of Droplet Disposition, Through 2027
Table 13: Global Market for Bioprinting Technologies, by Photopolymerization Technique, Through 2027
Table 14: Global Market for Bioprinting Technologies, by End Use, Through 2027
Table 15: 3D Printed Drug Delivery Systems
Table 16: Global Market for Bioprinting Technologies, by Region, Through 2027
Table 17: North American Market for Bioprinting Technologies, by Type, Through 2027
Table 18: North American Market for Bioprinting Technologies, by Type of Droplet Disposition, Through 2027
Table 19: North American Market for Bioprinting Technologies, by Photopolymerization Technique, Through 2027
Table 20: North American Market for Bioprinting Technologies, by End Use, Through 2027
Table 21: North American Market for Bioprinting Technologies, by Country, Through 2027
Table 22: European Market for Bioprinting Technologies, by Type, Through 2027
Table 23: European Market for Bioprinting Technologies, by Type of Droplet Disposition, Through 2027
Table 24: European Market for Bioprinting Technologies, by Photopolymerization Technique, Through 2027
Table 25: European Market for Bioprinting Technologies, by End Use, Through 2027
Table 26: European Market for Bioprinting Technologies, by Country, Through 2027
Table 27: Asia-Pacific Market for Bioprinting Technologies, by Type, Through 2027
Table 28: Asia-Pacific Market for Bioprinting Technologies, by Type of Droplet Disposition, Through 2027
Table 29: Asia-Pacific Market for Bioprinting Technologies, by Photopolymerization Technique, Through 2027
Table 30: Asia-Pacific Market for Bioprinting Technologies, by End Use, Through 2027
Table 31: Asia-Pacific Market for Bioprinting Technologies, by Country, Through 2027
Table 32: Rest of the World Market for Bioprinting Technologies, by Type, Through 2027
Table 33: Rest of the World Market for Bioprinting Technologies, by Type of Droplet Disposition, Through 2027
Table 34: Rest of the World Market for Bioprinting Technologies, by Photopolymerization Technique, Through 2027
Table 35: Rest of the World Market for Bioprinting Technologies, by End Use, Through 2027
Table 36: Rest of the World Market for Bioprinting Technologies, by Country, Through 2027
Table 37: Recent Developments in the Global Market for Bioprinting Technologies, 2018-2022
Table 38: 3D Bio Corp.: Product Portfolio
Table 39: 3D Bio Corp.: Recent Developments, 2022
Table 40: 3D Bioprinting Solutions: Product Portfolio
Table 41: 3D Bioprinting Solutions: Recent Developments, 2014-2021
Table 42: 3D Systems, Inc.: Product Portfolio
Table 43: 3D Systems, Inc.: Recent Developments, 2020-2022
Table 44: Advanced Solutions Inc.: Product Portfolio
Table 45: Advanced Solutions Inc.: Recent Developments, 2019-2021
Table 46: Aspect Biosystems Ltd.: Product Portfolio
Table 47: Aspect Biosystems Ltd.: Recent Developments, 2019-2022
Table 48: Cellink: Product Portfolio
Table 49: Cellink: Recent Developments, 2022
Table 50: Cyfuse Biomedical: Product Portfolio
Table 51: Cyfuse Biomedical: Recent Developments, 2019-2021
Table 52: CollPlant: Product Portfolio
Table 53: CollPlant: Recent Developments, 2022
Table 54: Organovo: Product Portfolio
Table 55: Organovo: Recent Developments, 2022
Table 56: Precise Bio: Product Portfolio
Table 57: Precise Bio: Recent Developments, 2018-2022
Table 58: Stratasys Ltd.: Product Portfolio
Table 59: Stratasys Ltd.: Recent Developments, 2022
Table 60: Other Bioprinting Startups

List of Figures
Summary Figure: Global Market for Bioprinting Technologies, by Type, 2019-2027
Figure 1: Medical Device Marketing Process in the U.S.
Figure 2: Global Population Aging 60+ Years, by Region, 2015-2050
Figure 3: Global Projected Diabetes Patients Aged 20-79, 2010 and 2030
Figure 4: Workflow Structure and Emergency Use Authorization of 3D Printed Products
Figure 5: Global Market Shares of Bioprinting Technologies, by Type, 2021
Figure 6: Global Market Shares of Bioprinting Technologies, by Type of Droplet Disposition, 2021
Figure 7: Global Market Shares of Bioprinting Technologies, by Photopolymerization Technique, 2021
Figure 8: Global Market Shares of Bioprinting Technologies, by End Use, 2021
Figure 9: Drug Discovery Pipeline with Retooling 3D Printing Technologies
Figure 10: North American Market Shares of Bioprinting Technologies, by Type, 2021
Figure 11: North American Market Shares of Bioprinting Technologies, by Type of Droplet Disposition, 2021
Figure 12: North American Market Shares of Bioprinting Technologies, by Photopolymerization Technique, 2021
Figure 13: North American Market Shares of Bioprinting Technologies, by End Use, 2021
Figure 14: North American Market Shares of Bioprinting Technologies, by Country, 2021
Figure 15: U.S. Elderly (65+ Years) Population, 2010-2050
Figure 16: European Market Shares of Bioprinting Technologies, by Type, 2021
Figure 17: European Market Shares of Bioprinting Technologies, by Type of Droplet Disposition, 2021
Figure 18: European Market Shares of Bioprinting Technologies, by Photopolymerization Technique, 2021
Figure 19: European Market Shares of Bioprinting Technologies, by End Use, 2021
Figure 20: European Market Shares of Bioprinting Technologies, by Country, 2021
Figure 21: Asia-Pacific Market Shares of Bioprinting Technologies, by Type, 2021
Figure 22: Asia-Pacific Market Shares of Bioprinting Technologies, by Type of Droplet Disposition, 2021
Figure 23: Asia-Pacific Market Shares of Bioprinting Technologies, by Photopolymerization Technique, 2021
Figure 24: Asia-Pacific Market Shares of Bioprinting Technologies, by End Use, 2021
Figure 25: Asia-Pacific Market Shares of Bioprinting Technologies, by Country, 2021
Figure 26: Rest of the World Market Shares of Bioprinting Technologies, by Type, 2021
Figure 27: Rest of the World Market Shares of Bioprinting Technologies, by Type of Droplet Disposition, 2021
Figure 28: Rest of the World Market Shares of Bioprinting Technologies, by Photopolymerization Technique, 2021
Figure 29: Rest of the World Market Shares of Bioprinting Technologies, by End Use, 2021
Figure 30: Rest of the World Market Shares of Bioprinting Technologies, by Country, 2021
Figure 31: Bioprinting Company Ranking Analysis, 2021
Figure 32: Top Bioprinting Startups Ranking, 2021

Samples

Loading
LOADING...

Executive Summary

The use of technology in medical devices impacts multiple therapeutic areas. The most significant user segments include tissue engineering, drug discovery, and regenerative medicine. As per the WHO, 21 patients per day die due to organ transplant shortages. Bioprinted organs could help clinicians and patients to eliminate the list of requirements of organs. The technology has been used as one of the most impactful possibilities in the field.

Laser bioprinting is growing at a high rate due to its advantages in high print speeds, high cell densities, good cell viability, and higher resolution patterns. Also, since there is no nozzle, there are no issues with a nozzle clogging with cells or other materials during printing.

The main advantage of the photopolymerization technique is achieving covalently crosslinked hydrogels, helping to drive the use and growth of these bioprinters. Advantages include the ability to print high-viscosity biomaterials, the creation of large constructs, high cell densities, sterile environments, and affordability.

Inkjet bioprinters have the advantages of high print speed, high cell viability, and high-resolution structures. Inkjet printers are limited to low-viscosity materials, and as a result, the printed structure may have weak mechanical properties.

Companies Mentioned

  • 3D Bio Corp.
  • 3D Bioprinting Solutions
  • 3D Systems Inc.
  • Advanced Solutions Inc.
  • Aspect Biosystems Ltd.
  • Cellink
  • Collplant Biotechnologies Ltd.
  • Cyfuse Biomedical
  • Organovo Holding Inc.
  • Precise Bio
  • Stratasys Ltd.